Curvebeam Ai Ltd - Asset Resilience Ratio
Curvebeam Ai Ltd (CVB) has an Asset Resilience Ratio of 8.27% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Curvebeam Ai Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2025)
This chart shows how Curvebeam Ai Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CVB asset base.
Liquid Assets Composition Over Time
This chart breaks down Curvebeam Ai Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore CVB long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$5.04 Million | 8.27% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$5.04 Million | 8.27% |
Asset Resilience Insights
- Limited Liquidity: Curvebeam Ai Ltd maintains only 8.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Curvebeam Ai Ltd Industry Peers by Asset Resilience Ratio
Compare Curvebeam Ai Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Curvebeam Ai Ltd (2023–2025)
The table below shows the annual Asset Resilience Ratio data for Curvebeam Ai Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 8.27% | AU$5.04 Million ≈ $3.57 Million |
AU$60.98 Million ≈ $43.15 Million |
-1.92pp |
| 2024-06-30 | 10.18% | AU$6.45 Million ≈ $4.56 Million |
AU$63.33 Million ≈ $44.81 Million |
+1.78pp |
| 2023-06-30 | 8.41% | AU$5.16 Million ≈ $3.65 Million |
AU$61.36 Million ≈ $43.42 Million |
-- |
About Curvebeam Ai Ltd
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot … Read more